SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing significant volatility and trending momentum as investors closely monitor upcoming blockchain upgrades and potential token burn events. The community remains deeply divided, with many traders speculating on a supply shock and potential price recovery while skeptics warn of pump-and-dump risks.

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as community members aggressively debate whether the token is primed for a new all-time high or if it is entering a period of exhaustion. Bullish traders are actively calling for others to hold through dips and push for higher volume, while skeptics warn of potential rug pulls and shift their attention to emerging meme coins.

MEME COIN: $ROAR is the OG token. Est. Sept '22. Inspired by The Roaring Kitty Who Inspired other to fight against wall street through Game Stop.  We Are  100% community-owned.  LP burnt.  Contract Renounced  Ready to Moon like $GME &amp; $AMC?

Roaring Kitty

The $ROAR token is seeing intense community-driven momentum as investors draw parallels between its community-led project model and the broader GameStop market sentiment. Discussions are dominated by speculation regarding potential exchange listings and the ongoing strength of the Roaring Kitty narrative, with holders emphasizing the project's decentralized, community-owned structure.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending as investors react to the companys recent announcement regarding the preliminary Phase 3 trial design for CAD-1005 in patients with Heparin-Induced Thrombocytopenia. While some community members are highlighting the clinical pipeline and long-term potential of the company's anti-thrombotic programs, others are actively debating concerns regarding share dilution and the heavy volume of automated posts surrounding the stock.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is drawing significant attention from investors seeking consistent monthly income, as community discussions highlight its role as a core holding for reliable cash flow in volatile markets. Investors are actively debating the fund's income-generating strategy and tax considerations compared to other high-yield Nasdaq-focused ETFs, while monitoring upcoming dividend announcements.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Equity Premium Income ETF

JPMorgan Equity Premium Income ETF

The JPMorgan Equity Premium Income ETF ($JEPI) remains a central focus for income-oriented investors, with recent community sentiment driven by its ability to provide monthly cash flow distributions amid broader market volatility. Investors are actively discussing the strategy's utility as a portfolio stabilizer and income generator, often comparing it to $JEPQ and other derivative-income funds to evaluate trade-offs between yield, tax treatment, and capital preservation.

Crexendo, Inc. engages in the provision of telecommunications services, broadband Internet services, and other cloud business services. It operates through the Cloud Telecommunications Services and Software Solutions segments. The Cloud Telecommunications Services segment focuses on selling cloud telecommunication products and services and broadband Internet services. The software solutions segment focuses on software licenses, software maintenance support and professional services. The company was founded on April 13, 1995 and is headquartered in Tempe, AZ.

Crexendo Inc

Crexendo is seeing significant community interest driven by consistent earnings beats and the company's expanding market share in the UCaaS space, particularly as competitors like Cisco and Microsoft shift their focus away from similar platforms. Investors are closely monitoring its recurring revenue growth, AI-powered feature integrations, and potential for future accretive acquisitions as the firm cements its position in the cloud communications market.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter's UPDOG token is generating significant community buzz, with supporters highlighting its two-year presence on the Solana network and inclusion on the Jupiter Strict List. While some market participants express skepticism regarding its legitimacy, the community remains actively engaged in promotional efforts and liquidity-focused initiatives.

VeChain, founded in 2015, is a sustainability-focused blockchain driving mass adoption of Web3. Its energy-efficient VeChainThor chain delivers fast, low-cost transactions, making blockchain accessible to millions worldwide. With partnerships including UFC, BCG, and Walmart, and over 2 million active users on VeBetter-powered apps, VeChain is proving real-world impact at scale.  In 2024, the VeChain Renaissance upgrade was launched, introducing Ethereum compatibility, dPoS consensus, and dynamic gas fees. It cut VTHO inflation and introduced StarGate NFT staking, where users lock VET to mint transferable NFTs that earn VTHO, can be delegated to validators, and serve as governance instruments. The upgrade also added new eco node tiers, lowering entry barriers while keeping rewards across higher staking levels.  By combining adoption, upgraded tokenomics, and inclusive staking, VeChain is positioning itself as a leading blockchain where usage, growth, and rewards fuel long-term value creation.

Vechain

VeChain is trending as investors debate the project's long-term utility against its recent lackluster price performance and declining market cap ranking. Community discussion is sharply divided between believers accumulating tokens in anticipation of network upgrades and long-term ecosystem development, and vocal skeptics frustrated by the lack of upward momentum compared to other altcoins.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is attracting significant investor attention as it prepares for a high-profile oral presentation at Digestive Disease Week, where community members anticipate the release of compelling clinical data on pancreatic cancer. The stock is currently trending due to a combination of clinical trial progress and institutional accumulation, with many investors expressing optimism about its potential for long-term growth and upcoming catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Advent Convertible & Income Fund operates as a closed-end investment fund, which focuses on convertible securities and non-convertible income securities. The company was founded on February 19, 2003 and is headquartered in New York, NY.

AVK
Advent Claymore Convertible Securities and Income Fund

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AVK News

AVKAdvent Claymore Convertible Securities and Income Fund